Novasep is building a new synthesis laboratory and a kilo lab for its U.S. facility, which will allow the contract manufacturing organization (CMO) to offer both chemistry and purification services. With the new capabilities, the company will be able to produce the initial kilogram scale batches of synthetic molecules that are needed for biological testing and preclinical trials. The company says the investment is a direct response to increasing demand from U.S. customers for closer proximity...